Research findings, pricing news, and vendor analysis across the peptide market.
Showing 1 to 10 of 10
REIMAGINE 5 directly compared CagriSema 1.0 mg/1.0 mg with tirzepatide 5 mg in adults with type 2 diabetes. Here is what the 12.4% versus 9.1% result means, what it does not prove, and how current cagrilintide, semaglutide, and tirzepatide prices and COA evidence compare.
Read more →PT-141, kisspeptin, and oxytocin target different parts of sexual desire and arousal. Compare the human evidence, current price per milligram, product identity, and COA proof before choosing a research product.
Read more →Semax and NAD+ nasal sprays target different buyer goals and use radically different milligram scales. Compare exact identity, current price per mg, metered-spray disclosure, storage, and lot-level testing before choosing.
Read more →Epitalon, MOTS-c, NAD+, and SS-31 occupy different longevity research lanes. Compare their evidence, biological-age tracking fit, current price per mg, vendor testing depth, and best buying use case before checkout.
Read more →KPV, BPC-157, and TB-500 occupy different inflammation and recovery research lanes. Compare the evidence, current price per mg, vendor testing depth, and best buying fit before checkout.
Read more →Pinealon and Epitalon come from the same short-peptide research tradition, but they are different sequences with different research lanes and prices. Compare EDR versus AEDG, current cost per mg, evidence depth, and the COA checks that matter before buying.
Read more →Zepbound is still the stronger weight-loss choice for buyers who can tolerate injections and get coverage. Foundayo is the simpler access play if you want a daily pill, lower direct-pay entry pricing, or a CVS Caremark path starting sooner.
Read more →Foundayo and the Wegovy pill are both oral GLP-1 options, but they are not interchangeable. Foundayo is the simpler daily pill with no fasting rule, while Wegovy pill has stronger semaglutide continuity, cardiovascular-label context, and clear NovoCare cash-pay pricing.
Read more →Eden Health and SkinnyRx both offer no-frills online GLP-1 access, but they differ on pricing clarity, medication formats, support, and who they fit best. This comparison gives a buyer-focused recommendation before you sign up.
Read more →One targets GLP-1 receptors. The other targets GLP-1 and GIP. Clinical trials show tirzepatide edges out semaglutide on weight loss — but the full picture is more nuanced.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
